AU2004229195B2 - Implant for the treatment of a cystocele and device for placement of said implant - Google Patents

Implant for the treatment of a cystocele and device for placement of said implant Download PDF

Info

Publication number
AU2004229195B2
AU2004229195B2 AU2004229195A AU2004229195A AU2004229195B2 AU 2004229195 B2 AU2004229195 B2 AU 2004229195B2 AU 2004229195 A AU2004229195 A AU 2004229195A AU 2004229195 A AU2004229195 A AU 2004229195A AU 2004229195 B2 AU2004229195 B2 AU 2004229195B2
Authority
AU
Australia
Prior art keywords
implant
degree
straps
posterior
anterior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004229195A
Other versions
AU2004229195A1 (en
Inventor
Jean-Marc Beraud
Emmanuel Delorme
Georges Eglin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANALYTIC BIOSURGICAL SOLUTION ABISS
Original Assignee
ANALYTIC BIOSURGICAL SOLUTION ABISS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANALYTIC BIOSURGICAL SOLUTION ABISS filed Critical ANALYTIC BIOSURGICAL SOLUTION ABISS
Publication of AU2004229195A1 publication Critical patent/AU2004229195A1/en
Application granted granted Critical
Publication of AU2004229195B2 publication Critical patent/AU2004229195B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06066Needles, e.g. needle tip configurations
    • A61B17/06109Big needles, either gripped by hand or connectable to a handle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0004Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
    • A61F2/0031Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
    • A61F2/0036Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
    • A61F2/0045Support slings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3415Trocars; Puncturing needles for introducing tubes or catheters, e.g. gastrostomy tubes, drain catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3468Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00805Treatment of female stress urinary incontinence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06004Means for attaching suture to needle
    • A61B2017/06042Means for attaching suture to needle located close to needle tip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06066Needles, e.g. needle tip configurations
    • A61B2017/06076Needles, e.g. needle tip configurations helically or spirally coiled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06066Needles, e.g. needle tip configurations
    • A61B2017/06085Needles, e.g. needle tip configurations having a blunt tip

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Prostheses (AREA)

Description

VERIFICATION OF TRANSLATION I, M arie-C laude N IE PS ........................................................ of .Cabinet Beau de Lom6nie, 158 rue de l'Universit6,. .75340 C 6dex 07, France...................................................... am the translator of Patent Application No PCT/FR2004/000766 and I state that the following is a true translation to the best of my knowledge and belief. (Signature of Translator) DATED this . ....... day of October 2005 [0001] The present invention concerns the technical field for the treatment of cystocele, in particular in the elderly woman. [0002] In general, cystocele phenomena result from the slackening of the suspension tissue of the urinary and genital organs, provoking disorders that require surgery. [0003] Thus, it has been provided attempts to reconstruct the natural system for the suspension of organs affected by this slackening, implementing non resorbent sutures or reinforcement strips. However, these techniques are not always satisfactory, in particular due to the requirement for a heavy surgical intervention, inducing a dissection of the anatomic regions not involved by the surgical repair for the non-resorbent sutures. [0004] So as to try to overcome these drawbacks the patent application FR 2 785 521 provides an implant wherein a support body from which two suspension cords at the end of which anchoring elements intended to form sutures on regions considered to be anatomically stable. This implant is then inserted by laparoscopy, thereby reducing the surgical procedure. [0005] However, such an implant has not been able for providing effective suspension, mainly due in particular to the stress applied to the regions considered to be anatomically stable. In addition, this type of implant does not have great stability in space in the conditions of use. 1 [0006] Therefore, the need appeared for an implant providing on one hand. better implant insertion stability and on the other hand, a technique that provides optimum stability while providing a maximum reduction of the patient's trauma. [0007] Thus, in order to achieve these objectives, the invention concerns an implant for the treatment of cystocele, presenting a thin a supple structure and comprising a support body from which two anterior suspension straps extending on both sides of a sagittal plane of the support body and two posterior suspension straps also arranged on both sides of the sagittal plane. [0008] According to an essential characteristic of the invention, the implant also comprises so-called middle suspension straps, extending from the support body on both sides of the sagittal plane and between the anterior and posterior straps. [0009] The implementation of six suspension straps then provides better distribution of the effort acting on the support body on the anatomic anchoring points of the straps, while guaranteeing better orientation in space of the support body implanted in the patient. [0010] According to a preferred but not strictly necessary characteristic of the invention, the anterior suspension straps are each intended to be fitted in one of the two ischeo-pubic foramen still called obturators or obturated foramen and. for this purpose, having a length exceeding 100 mm and, preferably, exceeding 2 120 mm. [0011] According to another characteristic of the invention, the longitudinal axes of the anterior straps form an angle alpha. exceeding 45.degree. and, preferably but not strictly necessarily, an angle a between 100.ldegree. and 1 80.degree. and, preferably between 115.degree. and 170.degree.. It should be noted that according to a preferred embodiment of the invention, the sagittal plane forms an axis of symmetry of the implant and thereby bisecting the angle .alpha.. [0012] According to another characteristic of the invention, the longitudinal axes of the posterior straps form an angle .beta. that is not zero. Thereby, the posterior straps are not to be considered to be parallel. Preferably. but not strictly necessarily, the angle beta. exceeds 10.degree. and is preferably between 1O.degree. and 75.degree. or even between, 1OO.degree. and 1 80.degree, according to the disorder treated. [0013] Preferably, the length of the posterior straps exceeds 100 mm and preferably 120 mm. [0014] According to another characteristic of the invention, the middle suspension straps also exceed 100 mm and, preferably 120 mm. [0015] According to another preferred by not strictly necessary characteristic of the invention, the shape of the support body is substantially rectangular. In a 3 preferred but not strictly necessary characteristic, the support body is between 60 mm and 90 mm long and between 40 mm and 60 mm wide. [0016] According to a preferred embodiment of the invention, the anterior straps substantially extend from the anterior comers of the support body and the posterior straps also extend from the posterior corners of the support body. [0017] The invention also concerns a surgical technique for the insertion of said implant and the treatment of cystocele. [0018] According to the invention, the main characteristic of this technique consists in inserting each one of the anterior suspension straps into one of the ischio-pubic foramen, also known as obturators or obturated foramen. [0019] As for the middle suspension straps they are each placed either in the middle translevator region, or into an obturated foramen in its infero-posterior region. [0020] While the posterior straps are either trans-fixed in the uterosacral ligaments or placed across the uterosacral ligaments then in the transgluteal region, preferably but not exclusively across the sacrosciatic ligaments. [0021] It should be noted that, according to this technique, the hold is mainly provided by friction between the implant and the tissues crossed and, more specifically, by friction between the suspension arm and the muscle tissue 4 crossed. [0022] Preferably, this technique is embodied during so-called mini-invasive surgery, using approach routes et the vicinity of the organs to treat, so as to reduce the time of surgery and blood loss. It is thereby possible to obtain a short post-surgical period with minimum patient discomfort. In addition, the simplicity of this technique makes it easy to reproduce and reduces the training required by surgeons to a maximum. [0023] The invention also concerns an introduction device that may be used without it being absolutely necessary according to the meaning of the invention for the insertion of the implant as disclosed above. [0024] The introduction device according to the invention comprises an introduction member with a supple structure and a shape similar to that of the implant and which comprises: [0025] a hollow body defining a cavity for the reception of the body of the implant, [0026] tubular branches extending from the hollow body, each defining a cavity for the reception of an implant suspension strap, [0027] means of traction extending from the end of each branch of the introduction member, 5 [0028] and means for cutting at least the hollow body of the introduction member. [0029] According to one characteristic of the invention, the means of traction comprise a semi-rigid needle for each tubular branch. [0030] According to the invention, the means for cutting may be implemented in any appropriate way, such as for example, through a line of lesser resistance likely to break when a traction is carried out at both tubular branches opposite of the introduction member. [0031] According to a preferred but not strictly necessary characteristic of the invention, the means for cutting comprise at least one aperture for the passage of a cutting tool. Preferably, the body of the introduction member comprises a series of apertures located close to a line corresponding to the sagittal plane of the implant as well as between the tubular branches. [0032] According to another characteristic of the invention, the introduction device comprises an implant in accordance with the invention, placed in the cavity of the hollow body and the tubular branches of the introduction member. Preferably but not strictly necessarily, the implant is free inside the introduction member. [0033] To facilitate the surgeon's work, according to another characteristic of the 6 invention, the introduction device also comprises at least an ancillary surgical material that comprises an elongated perforator guide or trocar whose end is intended to be introduced in the body of the patient, the other end of which is fitted with a handle. [0034] According to a characteristic of the invention, the perforator guide is curved in one plan. Preferably, but not strictly necessarily, the curved shape of the perforator extends over an angular sector exceeding 1 40.degree. and, preferably but not necessarily, inferior to 180.degree. and, preferably, between 1SO.degree. and 170.degree.. Preferably, the curved portion of the perforator guide is then curved with a radius of between 30 mm and 60 mm and, preferably, for the portion of the perforator guide extending from the handle to the end intended to be introduced in the patient's body of between 40 mm and 50 mm. the outer part of the perforator is then curved with a variable radius. [0035] According to another characteristic of the invention, the perforator guide has a helicoid shape at the opposite end of the handle or distal end. Preferably, the perforator guide then has the shape of a portion of helicoid spire extending over an angle of between 1 80.degree. and 360.degree. and, preferably, between 255.degree. and 270.degree.. Similarly, the spire of the perforator guide has preferably a radius of curvature between 20 mm and 40 mm, with a pitch between 15 mm and 25 mm. [0036] According to another characteristic of the invention, to reduce the trauma that the patient's body undergoes during the introduction of the implant, the 7 introduction device also comprises a tubular casing whose shape is complementary to that of the perforator guide. This tubular casing is then made to be fit on the perforator guide and to remain in the patient's body after removal of the perforator guide to define a tunnel for the passage of the means of traction of the introduction member. The tubular casing is then removed, after passage of the means of traction when the introduction device is removed. [0037] According to the invention, the tubular casing may be made of any supple biocompatible material such as, for example, but not exclusively, PVC. [0038] Different other characteristics of the invention follow from the above description with reference to the appended drawings that illustrate different embodiments of the implant according to the invention, as well as introduction members making the insertion of the said implant possible. [0039] Moreover, it should be noted that the different characteristics of the invention disclosed above and hereafter, may be combined in different alternatives, with relation to the disorder to treat. [0040] FIG. 1 is an elevation front view of an implant according to the invention, more particularly intended for the treatment of cystocele. [0041] FIG. 2 is an elevation view, partially removed, of a perforator guide that may be used for the insertion of an implant according to the invention with a curved shape. 8 [0042] FIG. 3 is an elevation view of another embodiment of a perforator guide according to the invention, with a helicoid-shaped introduction end. [0043] FIG. 4 is a left view of the perforator guide according to FIG. 3. [0044] FIG. 5 is a viex from below of the perforator illustrated in FIG. 3. [0045] FIG. 6 is a view of an introduction member according to the invention, enabling the insertion of the implant shows on FIG. 1. [0046] FIG. 7 to 10 are views, similar to FIG. 2 to 3, showing alternatives of the perforator guides for the insertion of an implant according to the invention. [0047] A preferred application of the invention is for the treatment of cystocele. For this purpose, the invention proposes an implant more particularly designed for this disorder and on the whole indicated by reference 1 in FIG. 1. The implant 1 has a thin and supple structure and is made of an adapted bio compatible material, such as, for example, a synthetic, woven or non woven, or knit material made of polypropylene or polyester fibres. Such a synthetic material may or may not be coated with products favouring cell growth. Similarly, the implant according to the invention, may be made of natural materials such as 'fascia latta" or even any biological or synthetic resorbent material. 9 [0048] According to an essential characteristic of the invention, implant 1 comprises a support body 2 from which two anterior suspension straps 3 extend on both side of a sagittal plane S. The implant also comprises two posterior suspension straps 4 also extending on each side of the sagittal plane S. Furthermore, implant 1 comprises two middle suspension straps 5 that extend from the support body 2 on sides of sagittal plane S, between the corresponding anterior straps 3 and posterior straps 4. [0049] According to the example shown, the shape of support body 2 is substancially rectangular, without such a shape being considered as necessary according to the invention and the anterior and posterior suspension straps 3 and 4, each extend from a corner of the body 2. It should be noted that, preferably, sagittal plane S corresponds to a plane of symmetry of implant 1. [0050] According to a preferred characteristic, related to the technique for the implementation provided by the invention, anterior straps 3 are more particularly intended to be introduced in one of the two ischio-pubic foramen of the subject to treat. For this purpose, the longitudinal axes A.sub.3 of anterior straps 3 form an angle alpha., preferably but not necessarily exceeding 45.degree., preferably between 1OO.degree. and 180.degree., preferably between 115 and 170.degree.. In addition, to enable easy insertion of anterior straps 3 in the corresponding ischio-pubic or obturated foramen, the length of the anterior straps L3, measured between the distal end of each anterior strap 3 and support body 2, exceeds 100 m and preferably is equal to or exceeds 120 mm. 10 [0051] As for the posterior straps 4, and as will appear subsequently, posterior straps 4 are more particularly intended to pass through uterosacral ligaments and, for this purpose, the longitudinal axes A.sub.4 of posterior suspension straps 4 form an angle beta., preferably but not exclusively not zero, preferably exceeding 1O.degree. and, even more preferably, between 1O.degree. and 75.degree.. It should be noted that, to facilitate the insertion, the length L.sub.4 of posterior suspension straps 4, measured between the distal end of the straps and support body 2, preferably exceeds 100 mm, even more preferably equals or exceeds 120 mm. [0052] As for the middle suspension straps 5, they are intended to be passed across the uterosacral ligaments, and for this purpose, the longitudinal axis A.sub.5 of each middle suspension strap 5, forms. along with the anterior part of sagittal plane, an angle .gamma., preferably but not necessarily of between 1 0.degree. and 140.degree. and, preferably between 11 O.degree. and 130.degree. and, in even more preferably, of between 11 5.degree. and 1 25.degree.. Such as the other anterior and posterior suspension straps 3 and 4. the length L.sub.5 of middle suspension straps 5, measured between the distal end of the middle suspension straps 5 and support body 2, preferably exceeds 100 mm and, more particularly preferably, exceeds or equals 120 mm. [0053] Moreover, the width of suspension straps 3, 4, 5 is chosen, preferably but not exclusively, to be between 5 mm and 15 mm and, for example, about ten millimetres. 11 [0054] Implant 1, as described above, is intended to be inserted in the anterior vaginal wall of a patient. For this purpose, for reducing the dissection of this region and the resulting trauma to a minimum, the invention proposes that the surgeon use one or several elongated perforator guides 10, such as those more particularly shown on FIGS. 2 and 3 to 5. [0055] Such a perforator guide 10 commonly comprises an elongated body or chuck 11, one end 12 of which is intended to be introduced in the body of the subject to be treated and the other end 13 is fitted with a handle 14. It should be noticed that introduction end 12 is preferably formed by a foam tip, that is, a non-traumatic tip that is not likely to wound or cut the tissue in which it has to be introduced. [0056] According to one embodiment shown on FIG. 2, perforator guide 10 is curved in one plane. This curved shape in one plane is especially adapted for the insertion of suspension straps in the anterior and posterior regions of the obturated foramen, Preferably but not strictly necessarily, the curved portion of the perforator guide is thereby has a radius of curvature R of between 30 mm and 60 mm and, preferably, for portion 15 of perforator guide 10 extending from handle 14 to end 12, between 40 mm and 50 mm, the outer part 16 of the perforator guide 10 thereby has a variable radius of curvature. [0057] According to another implementation of perforator guide 10, shown on FIG. 3 to 5, the elongated body 11 of guide 10 has a helicoid shaped end 17, also adapted for the insertion of suspension straps in the anterior or posterior 12 regions of the obturated foramen. Preferably, the distal end 17 of the perforator guide thereby has the shape of a portion of helicoid spire extending over an angle gamma. of between 180.degree. and 360.degree. and, preferably, between 255.degree. and 270.degree.. Also preferably, spire 17 of the perforator guide has a radius of curvature of between 20 mm and 40 mm, with a pitch of between 15 mm and 25 mm. [0058] The surgical treatment of cystocele, by means of an implant 1 and perforator guides 10, as previously described, is carried out as follows. [0059] The patient to be treated is first given an anaesthetic that may be general, regional or even local, according to the preference of the surgeon and the state of health of the patient. The operating position of the patient on the operating table will be that of usual vaginal surgery, that is with the patient's buttocks slightly outside of the surgical table and the thighs slightly bent on the abdomen. [0060] A dissection of the region of intervention is then carried out by respecting the attachments of the bladder neck. Traction is first exerted on the neck of the uterus, for example by means of Muze forceps, in order to expose the anterior fomix of the vagina. A vaginal incision, called horizontal pre-cervical incision, may thereby be carried out on the anterior side of the neck of the uterus, cross wise on the cervical side of the fomix of the vagina, well exposed by the traction. The entire edge of the anterior vaginal section is then taken hold: vaginal skin and Halban's fascia, by means of, for example, three Alis forceps 13 that are drawn upwards to expose the vesico-vaginal plane. A vesico-vaginal detachment is then progressively carried out by everting the anterior vaginal wall, This detachment is halted at the bottom and in the middle, just above the bladder neck. while it is carried out below and laterally up to the arcatus tendinus fascia pelvis. This area of the arcatus tendinus fascia pelvis is then opened toward the obstructed foramen, so as to enable the introduction of a finger behind the obturator muscle. Similarly, the detachment practiced at the top, at the level of the vaginal incision, should enable the introduction of a finger against the levator muscle. [0061] Once the dissection is carried out, the first anterior suspension strap 3 may be inserted in the corresponding ischio-pubic foramen. For this purpose, a curved or helicoid perforator guide 10 is used, as previously described, depending of the surgeon's choice; First, a punctiform incision is carried out preferably about 15 mm outside of the ischio-pubic branch at the horizontal level with respect to the clitoris cap. A finger is then inserted behind the obstructed foramen, so as to receive the introduction end or tip 12 of perforator guide 10. introduced by the puctiform incision. Perforator guide 10 is then inserted, led by the finger until the anterior vaginal incision. [0062] At this stage, anterior suspension strap 3 is secured on the perforator guide, for example at the level of an eye 19 at the introduction end 12 of this guide. Once secured, the perforator guide is removed, thereby providing a traction on the anterior suspension strap that is then introduced through the obstructed foramen. 14 [0063] The same surgical procedure is repeated for the introduction of the second anterior suspension strap 3. [0064] It should be noted that the anterior suspension straps 3 are preferably positioned without traction to prevent the dysuric effect of implant 1 that is placed just above and behind the bladder neck. [0065] The first middle suspension strap 5 is then put in place. [0066] For this purpose, a punctiform incision is made in the genitocrural groove, horizontally with respect to the posterior commissure of the labia majora. Perforator guide 10 is then introduced by this incision to be led through the levator muscle. It should be noted that the end of perforator guide 10 is then located just within the ischio-public branch, one finger placed against the upper side of the levator muscle receiving the tip of the perforator guide to lead it into the anterior vaginal incision. [0067] The end of middle suspension strap 5 to be placedis then secured at the end 12 of perforator guide 10 which is then removed in the opposite direction to bring along with themiddle suspension strap 5. [0068] The same surgical procedure is then repeated for the insertion of the second middle suspension strap 5. 15 [0069] It should be noted that the middle suspension straps 5 are preferably placed, without any traction or mechanical bias, to prevent the cord effect of the fibroid prosthetic strap in the latero-vesicovaginal grooves. [0070] According to an alternative implant, the middle suspension straps 5 may also be implanted through a corresponding obstructed foramen, in its lower posterior part opposite to the ischium. [0071] At this stage of the insertion of implant 1, the anterior edge of the implant is preferably secured by one or several, preferably two or three resorbent stitches at the anterior side of the neck of the uterus. [0072] The insertion of implant 1 continues by the entry of posterior suspension straps 4. It should be noticed that the posterior suspension straps 4 are essential in case of hysterectomy without conservation of the neck. [0073] A first posterior suspension strap 4 is placed through the base of the broad ligament and through the base of the uterosacral ligament. For this purpose, perforator guide 10 is introduced from the rear vaginal wall to the front through the uterosacral ligament. Posterior strap 4 is then secured to the perforator guide and drawn in a reverse direction from front to back through the uterosacral ligament. [0074] The same surgical procedure is repeated for the insertion of the second posterior suspension strap 4. 16 [0075] The posterior suspension straps 4 may then be left free after crossing the uterosacral ligaments or on the contrary each be secured by a resorbent suture to the prerectal plate. [0076] According to an alternative of the invention, the posterior suspension straps 4 are each passed first through the corresponding uterosacral ligament, then through the sacrosciatic ligament by means of the perforator guide 10 that will have gone into the transgluteal pathway zone. [0077] The operation finishes with the closing of the vaginal incision by means of resorbent continuous suture as well as the closing of the punctiform incisions also by means of resorbent thread. [0078] At the end of the intervention, a vaginal wick is inserted as well as a bladder probe that are removed forty-eight hours after the intervention. The post-urinary residues are then measured by probe, to make sure that the bladder emptying is satisfactory, so as to authorise the patient's discharge. [0079] The intervention to treat the cystocele lasts about one hour and the average period of hospitalisation is four days. The patient's activity will be restricted for one month and a bath should be avoided during the same period of time. Finally, it is advisable to plan for six weeks of sexual abstinence after the operation. 17 [0080] Therefore, the technique proposed only treats the disorder, that is the imbalance in the pelvic statics and thereby restores as normal an anatomy as possible by preserving the individual's body image. This technique advantageously keeps the healthy organs or does not have an unfavourable effect on the pelvic statics. Indeed, the possibility of cancer will have been eliminated by the pre-surgical assessment and it will be possible to provide reliable gynaecological monitoring after the surgery. [0081] Moreover, there are very low risks of pelvic genital cancer and, in addition, the treatment proposed by the invention does not complicate subsequent access to the genital organs. [0082] As indicated above, the implant according to the invention is preferably inserted so as not to have any residual tension after insertion. To facilitate this surgical procedure, an alternative of the intervention proposes the use of an introduction member, more particularly shown on FIG. 6 and indicated as a whole in reference 20. [0083] This introduction member has a supple structure and its shape is similar to that of the implant. Introduction member 20 is preferably made of a bio compatible polymer from the family of plastics with a low friction coefficient, such as, for example, polyethylene. Introduction member 20 thereby comprises a hollow body 21 defining a cavity for the reception of body 2 of implant 1. Introduction member 20 also comprises tubular branches 22 that extend from the hollow body 21 and that each define a cavity for the reception of a 18 suspension strap 3, 4 and 5 of the implant 1. Each tubular branch 22 thereby has means of traction 23 extending from the corresponding free end of branch 22. The means of traction 23 may be provided in any appropriate manner such as, for example, systems for the coupling of the ends of branches 22 on a perforator guide 10. According to the example illustrated in FIG. 6, the means of traction 23, comprise for each branch 22, a soft or semi-rigid needle with a non traumatic or foam tip. Such a needle may be made of the same material as the material used for the introduction device 20 or, more generally, of a biocompatible plastic, preferably with a low friction coefficient. [0084] Finally, introduction member 20 comprises means for cutting 24 whose function will appear hereafter, of at least the hollow body 21 of the introduction member 20. The means for cutting 24 may then be carried out in any appropriate manner and, according to the example illustrated, include a series of six apertures 24 made at the periphery of hollow body 21, between each of the tubular branches 22, to enable the passage of a cutting tool to provide the cutting of the hollow body 21 according to lines 25 delimited by the mixed dashes in FIG. 6. [0085] Implant 1 is placed inside of hollow body 21 and tubular branches 22, being preferably free inside of the hollow body and of the tubular branches, so that the stress exerted on introduction member 20 is not transmitted to implant 1 itself. [0086] The insertion of implant 1 by means of introduction member 20 thereby 19 formed. is carried out according to the same surgical procedure described above, the removal and cutting of the introduction member 20 occur after the insertion of the whole suspension branches in the patient's body or, more specifically, corresponding tubular branches 22. The removal of the different members of the introduction member 20 by the traction exerted two by two on the opposite tubular branches 22 thereby enables the insertion of implant 1, without any stress, on the introduction member, so that it is found in a state that may be qualified as slack. [0087] In the examples of the treatment and operation described above, the introduction device used comprises simple perforator guides 10. Nevertheless, to try to reduce the trauma by abrasion of the tissue areas crossed to a maximum, it is possible to use an ancillary associating the perforator guide 10 to a soft casing 50 whose shape is complementary to that of guide 10. as illustrated in FIGS. 7 and 8 to 10. Casing 50 is inserted on perforator guide 10 that then has a stop device or guard 51 on which casing 50 comes up against during the introduction of perforator guide 10 in the patient's body. Casing 50 is left in the patient's body after removal of perforator guide 10 and before insertion of implant 1, 29, 39. The casing used thereby enables the creation of a channel for the passage of a traction element 23 of the introduction member 20 and wherein a tubular branch 23 and associated suspension strap 3, 4, 5 or a suspension strap 3, 4, 5 may be moved by sliding, so as to adjust the position of implant 1, 29, 39 without abrasion of the tissue crossed. A casing 50 is then used for the insertion of each suspension strap 3, 4, 5. The casings 50 are then removed along with the tubular branches 23 covering the suspension branches 20 of the implant or when the implant is inserted bare after adjusting the implant position. [0088] Thereby, the use of the casings 50 avoids acute inflammatory phenomena and reduces tissue trauma as long as the implant sites consist of very specialised muscle tissue that lost a large part of their ability to quickly regenerate and heal. [0089] Of course, different other modifications may be provided for the invention within the scope of the invention. 21

Claims (4)

1. An implant, for the treatment of cystocele, having a thin and supple structure, characterised in that it comprises a support body (2) from which axtend at least: two anterior suspension straps (3) on both sides of a sagittal plane (S), two posterior suspension straps (4) on both sides of a sagittal plane (S), and two middle suspension straps (5) on both sides of a sagittal plane (S) and between the anterior and the posterior straps (3) and (4).
2. An implant according to claim 1, characterised in that the longitudinal axes (A.sub.3) of the anterior straps (3) form an angle (.alpha.) exceeding
45.degree.. 3. An implant according to claim 2, characterised in that the longitudinal axes (A.sub.3) of the anterior straps (3) form an angle (.alpha.) between 1 00.degree. and 1 80.degree.. 4. An implant according to claim 2, characterised in that angle (.alpha.) is between 115.degree. and 170.degree.. 5. An implant according to claim 1, characterised in that the longitudinal axes (A.sub.4) of the posterior straps (4) form an angle (.beta.) that is not zero. 6. An implant according to claim 5, characterised in that the angle (.beta.) exceeds 10.degree.. 22 7. An implant according to claim 6, characterised in that the angle (.beta.) is between 10.degree. and 75.degree.. 8. An implant according to claim 7, characterised in that angle (.beta.) is between 1OO.degree. and 180.degree.. 9. An implant according to claim 1, characterised in that the longitudinal axis (A.sub.5) of each middle suspension strap (5) forms, with the anterior part of the sagittal plane (S), an angle (.gamma.) of between 100.degree. and 140.degree.. preferably between 11 0.degree. and 1 30.degree.. 10. An implant according to claim 1, characterised in that the length of the anterior straps (3) exceeds 100 mm and, preferably 120 mm. 11. An implant according to claim 1, characterised in that the length of the posterior straps (4) exceeds 100 mm and, preferably exceeds or equals 120 mm. 12. An implant according to claim 1, characterised in that the length of the middle straps (5) exceeds 100 mm and, preferably exceeds or equals 120 mm. 13. An implant according to claim 1, characterised in that the whole shape of the support body (2) is substantially rectangular. 23 14. An implant according to claim 13, characterised in that the length (L.sub.2) of the support body (2) is between 60 and 90 mm and the width is between 40 and 60 mm. 15. An implant according to claim 13, characterised in that the anterior straps (3) substantially extend from the posterior corners of the support body (2). 16. An implant according to claim 1, characterised in that the posterior straps (4) substantially extend from the posterior corners of the support body (2). 17. A device for the introduction of an implant (1) according to claim 1, characterised in that it comprises an introduction member (20) that has a supple structure and whose shape is similar to that of the implant (1) and that comprises: a hollow body (21) defining a cavity for the reception of the body (2) of the implant (1), tubular branches (22) extending from the hollow body (21) each defining a cavity for the reception of a suspension strap (3, 4, 5) of the implant (1), means of traction (23) extending from the end of each of the branches (22) of the introduction member, and means for cutting (25) at least the hollow body (21) of the introduction member (20). 18. An introduction device according to claim 17, characterised in that the means of traction (23) include a semi-rigid needle for each tubular branch (21). 19. An introduction device according to claim 17, characterised in that the means for cutting comprise at least one aperture (24) for the passage of a 24 cutting instrument. 20. An introduction device according to claim 17, characterised in that it comprises an implant (1) according to any of claims 1 to 16 placed in the cavity of the hollow body (21) and the tubular branches (22). 21. An introduction device according to claim 20, characterised in that the implant (1) is free inside the introduction device (10). 22. An introduction device according to claim 17, characterised in that it also comprises an elongated perforator guide (10) or trocar, one end (12) of which is made to be introduced in the patient's body and the other end is equipped with a handle (14). 23. An introduction device according to claim 22, characterised in that the shape of the perforator guide (10) is curved in one plane. 24. An introduction device according to claim 23, characterised in that the curved part (15) of the perforator (10) extends over an angular sector exceeding
140.degree. and, preferably under 180.degree., and in a particularly preferred manner, between 150.degree. and 170.degree.. 25. An introduction device according to claim 23, characterised in that the curved part (15) of the perforator guide (10) has a radius of curvature .RTM. of between 30 mm and 60 mm and, preferably, for the part of the perforator guide 25 extending from the handle to the end made to be introduced in the patient's body, of between 40 mm and 50 mm. 26. An introduction device according to claim 22, characterised in that the perforator guide (10) has a helicoid shape at the end opposite to the handle or distal end (17). 27. An introduction device according to claim 26, characterised in that the distal end (17) of the perforator guide (10) has the shape of a portion of helicoid spire extending over an angle of between 1 80.degree. and 350.degree. and, preferably, between 255.degree. and 270.degree.. 28. An introduction device according to claim 27, characterised in that the spire (17) of the perforator guide (10) has a radius of curvature of between 20 mm and 40 mm, with a pitch between 15 mm and 25 mm. 29. An introduction device according to claim 22, characterised in that it also comprises a removable tubular casing (50) whose shape is complementary to that of the perforator guide (10), intended to be fit on the perforator guide (10) and remain in the patient's body after the removal of the perforator guide (10) to define a tunnel for the passage of the means of traction (23) of the introduction member (20). 30. A procedure for the treatment of cystocele in women, characterised in that it consists essentially of: using an implant (1) according to claim 1; inserting the 26 implant (1) in the body of the patient by placing: each of the anterior suspension straps (3) in an obstructed hole, each of the middle suspension straps (5) in a corresponding middle translevator region, each of the posterior suspension straps (4) in a corresponding uterosacral region, and the support body (2) in the anterior vaginal wall. 31. A procedure for the treatment of cystocele in women. characterised in that it consists essentially of: using an implant (1) according to claim 1; inserting the implant (1) in the body of the patient by placing: each of the anterior suspension straps (3) in an obstructed hole, each of the middle suspension straps (5) in an inferoposterior region of the corresponding obstructed hole, each of the posterior suspension straps (4) in a corresponding uterosacral region, and the support body (2) in the anterior vaginal wall. 32. Procedure for the treatment of cystocele in women according to claim 30, characterised in that it in particular consists of placing each of the posterior suspension straps through the corresponding uterosacral ligament. 33. Procedure for the treatment of cystocele in women according to claim 30, characterised in that it in particular consists of placing each of the posterior suspension straps (4) through the corresponding uterosacral ligament and in the corresponding transgluteal region. 34. Procedure for the treatment of cystocele in women according to claim 33, characterised in that it in particular consists of placing each of the posterior 27 suspension straps (4) through the corresponding uterosacral ligament and through the corresponding sacrosciatic ligament. 28
AU2004229195A 2003-03-28 2004-03-26 Implant for the treatment of a cystocele and device for placement of said implant Ceased AU2004229195B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0303895A FR2852818B1 (en) 2003-03-28 2003-03-28 IMPLANT FOR THE TREATMENT OF THE CYSTOCELE AND DEVICE FOR THE PLACEMENT OF THIS IMPLANT
FR03/03895 2003-03-28
PCT/FR2004/000766 WO2004091443A2 (en) 2003-03-28 2004-03-26 Implant for the treatment of a cystocele and device for placement of said implant

Publications (2)

Publication Number Publication Date
AU2004229195A1 AU2004229195A1 (en) 2004-10-28
AU2004229195B2 true AU2004229195B2 (en) 2009-05-14

Family

ID=32947272

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004229195A Ceased AU2004229195B2 (en) 2003-03-28 2004-03-26 Implant for the treatment of a cystocele and device for placement of said implant

Country Status (11)

Country Link
EP (1) EP1610715B1 (en)
AU (1) AU2004229195B2 (en)
BR (1) BRPI0408904B8 (en)
CA (1) CA2520727C (en)
DK (1) DK1610715T3 (en)
ES (1) ES2712470T3 (en)
FR (1) FR2852818B1 (en)
PL (1) PL1610715T3 (en)
RU (1) RU2005131717A (en)
TR (1) TR201902838T4 (en)
WO (1) WO2004091443A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351197B2 (en) * 2004-05-07 2008-04-01 Ams Research Corporation Method and apparatus for cystocele repair
CA2582105C (en) * 2004-10-05 2014-04-01 Ams Research Corporation Method for supporting vaginal cuff
EP1909687A1 (en) 2005-07-13 2008-04-16 Boston Scientific Scimed, Inc. Snap fit sling anchor system and related methods
EP3533416A1 (en) 2005-07-25 2019-09-04 Boston Scientific Limited Pelvic floor repair system
US7878970B2 (en) 2005-09-28 2011-02-01 Boston Scientific Scimed, Inc. Apparatus and method for suspending a uterus
US9144483B2 (en) 2006-01-13 2015-09-29 Boston Scientific Scimed, Inc. Placing fixation devices
WO2007106897A2 (en) 2006-03-15 2007-09-20 Dennis Miller System and method for treating tissue wall prolapse
CA2644983C (en) 2006-03-16 2015-09-29 Boston Scientific Limited System and method for treating tissue wall prolapse
KR20090012217A (en) * 2006-04-14 2009-02-02 에이엠아이 어젠시 포 메디컬 이노베이션스 게엠베하 Implantable mesh for surgical reconstruction in the area of the pelvic floor
US8911348B2 (en) 2010-09-02 2014-12-16 Boston Scientific Scimed, Inc. Pelvic implants and methods of implanting the same
FR2975585B1 (en) 2011-05-23 2013-05-31 Mdb Texinov Sa TEXTILE IMPLANT AND METHOD FOR PRODUCING THE SAME
US9168120B2 (en) 2011-09-09 2015-10-27 Boston Scientific Scimed, Inc. Medical device and methods of delivering the medical device
RU2476174C2 (en) * 2011-12-29 2013-02-27 Олег Николаевич Шалаев Method of surgical treatment of isolated incomplete or complete prolapse of cervix
US9814555B2 (en) 2013-03-12 2017-11-14 Boston Scientific Scimed, Inc. Medical device for pelvic floor repair and method of delivering the medical device
IT201700105278A1 (en) * 2017-09-20 2019-03-20 Nardo Tola Network surgical device for laparoscopic use
FR3072019A1 (en) 2017-10-05 2019-04-12 Centre Hospitalier Regional Universitaire De Lille NON-RESORBABLE BIOCOMPATIBLE TEXTILE, ABLE TO BE IMPLANTED, PARTICULARLY AT THE PELVIC AREA OF AN ASSOCIATED PATIENT-PROSTHESIS
US10874541B2 (en) 2017-11-09 2020-12-29 11 Health And Technologies Limited Ostomy monitoring system and method
USD893514S1 (en) 2018-11-08 2020-08-18 11 Health And Technologies Limited Display screen or portion thereof with graphical user interface

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2199690A (en) * 1936-07-20 1940-05-07 Bullard Co Mask
US4377157A (en) * 1980-10-06 1983-03-22 New Mexico State University Foundation, Inc. Intravaginal anchoring device
EP0774240A1 (en) * 1995-11-17 1997-05-21 Ethicon, Inc. Implant for suspension of the urinary bladder in cases of incontinence of urine in women
FR2785521A1 (en) * 1998-11-10 2000-05-12 Sofradim Production SUSPENSION DEVICE FOR THE TREATMENT OF PROLAPSUS AND URINARY INCONTINENCES
WO2001006951A1 (en) * 1999-07-27 2001-02-01 Angiologica B.M. S.R.L. Corrective mesh for body tissues
WO2002038079A2 (en) * 2000-11-13 2002-05-16 Ethicon Gmbh Implant for holding the female bladder
WO2002058563A1 (en) * 2001-01-23 2002-08-01 American Medical Systems, Inc. Implantable sling

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5394568A (en) * 1993-01-28 1995-03-07 Minnesota Mining And Manufacturing Company Molded head harness

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2199690A (en) * 1936-07-20 1940-05-07 Bullard Co Mask
US4377157A (en) * 1980-10-06 1983-03-22 New Mexico State University Foundation, Inc. Intravaginal anchoring device
EP0774240A1 (en) * 1995-11-17 1997-05-21 Ethicon, Inc. Implant for suspension of the urinary bladder in cases of incontinence of urine in women
FR2785521A1 (en) * 1998-11-10 2000-05-12 Sofradim Production SUSPENSION DEVICE FOR THE TREATMENT OF PROLAPSUS AND URINARY INCONTINENCES
WO2001006951A1 (en) * 1999-07-27 2001-02-01 Angiologica B.M. S.R.L. Corrective mesh for body tissues
WO2002038079A2 (en) * 2000-11-13 2002-05-16 Ethicon Gmbh Implant for holding the female bladder
WO2002058563A1 (en) * 2001-01-23 2002-08-01 American Medical Systems, Inc. Implantable sling

Also Published As

Publication number Publication date
EP1610715B1 (en) 2018-11-28
WO2004091443A3 (en) 2004-12-23
PL1610715T3 (en) 2019-07-31
TR201902838T4 (en) 2019-03-21
EP1610715A2 (en) 2006-01-04
RU2005131717A (en) 2006-08-10
BRPI0408904B8 (en) 2021-06-22
BRPI0408904B1 (en) 2015-07-28
CA2520727C (en) 2012-12-18
ES2712470T3 (en) 2019-05-13
FR2852818B1 (en) 2005-06-24
FR2852818A1 (en) 2004-10-01
DK1610715T3 (en) 2019-03-18
WO2004091443A2 (en) 2004-10-28
BRPI0408904A (en) 2006-03-28
AU2004229195A1 (en) 2004-10-28
CA2520727A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
US7494495B2 (en) Method and implant for curing cystocele
AU2004229194B2 (en) Implant for treatment of a rectocele and device for placement of said implant
AU2004229195B2 (en) Implant for the treatment of a cystocele and device for placement of said implant
US8801593B2 (en) Method of treating anal incontinence
JP4241389B2 (en) Method and apparatus for treatment of pelvic prolapse in female patients
KR100943400B1 (en) A surgical kit and a mesh for supporting a prolapsed bladder
US8109867B2 (en) Tubular mesh for sacrocolpopexy and related procedures
US8425400B2 (en) Implant for supporting the urethra of a man and a surgical kit for treating incontinence in a man and including such an implant
US8500625B2 (en) Surgical kit for treating urinary incontinence in man
EP1715809A1 (en) Prolapse repair
EP2943147B1 (en) Surgical implant for the treatment of the prolapse of a pelvic organ by laparoscopy via sacrocolpopexy and/or sacrohysteropexy
US10039627B2 (en) Medical device and method of delivering the medical device
MX2011005631A (en) Implant for treating a genital prolapse, and associated treatment method.
AU2015201961B2 (en) Method of treating anal incontinence
AU2013201412B2 (en) Method of treating anal incontinence

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired